The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis

References

• Saito H. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol 2005; 137:319 - 25; http://dx.doi.org/10.1159/000086464; PMID: 15970641
   PubMed Web of Science ®Google Scholar
• Kapoor R, Menon C, Hoffstad O, Bilker W, Leclerc P, Margolis DJ. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008; 58:68 - 73; http://dx.doi.org/10.1016/j.jaad.2007.06.041; PMID: 17692428
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011; 127:1420 - 32; http://dx.doi.org/10.1016/j.jaci.2011.01.054; PMID: 21419481
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts. J Allergy Clin Immunol 2011; 127:1110 - 8; http://dx.doi.org/10.1016/j.jaci.2011.01.053; PMID: 21388665
   PubMed Web of Science ®Google Scholar
• Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS, Chan LS. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004; 138:375 - 87; http://dx.doi.org/10.1111/j.1365-2249.2004.02649.x; PMID: 15544612
   PubMed Web of Science ®Google Scholar
• Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117:977 - 83; http://dx.doi.org/10.1046/j.0022-202x.2001.01484.x; PMID: 11676841
   PubMed Web of Science ®Google Scholar
• Chen L, Lin SX, Agha-Majzoub R, Overbergh L, Mathieu C, Chan LS. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model. Int Immunol 2006; 18:1233 - 42; http://dx.doi.org/10.1093/intimm/dxl054; PMID: 16735375
   PubMed Web of Science ®Google Scholar
• Bao L, Shi VY, Chan LS. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis. Mol Immunol 2012; 50:91 - 7; http://dx.doi.org/10.1016/j.molimm.2011.12.008; PMID: 22226123
   PubMed Web of Science ®Google Scholar
• Chen L, Lin SX, Overbergh L, Mathieu C, Chan LS. The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE. Clin Exp Immunol 2005; 142:21 - 30; http://dx.doi.org/10.1111/j.1365-2249.2005.02894.x; PMID: 16178852
   PubMed Web of Science ®Google Scholar
• Chen L, Marble DJ, Agha R, Peterson JD, Becker RP, Jin T, et al. The progression of inflammation parallels the dermal angiogenesis in a keratin 14 IL-4-transgenic model of atopic dermatitis. Microcirculation 2008; 15:49 - 64; http://dx.doi.org/10.1080/10739680701418416; PMID: 17952801
   PubMed Web of Science ®Google Scholar
• Shi VY, Bao L, Chan LS. Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4-transgenic mouse model. Microcirculation 2012; 19:567 - 79; http://dx.doi.org/10.1111/j.1549-8719.2012.00189.x; PMID: 22574929
   PubMed Web of Science ®Google Scholar
• Chen L, Lin SX, Amin S, Overbergh L, Maggiolino G, Chan LS. VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model. Immunol Cell Biol 2010; 88:334 - 42; http://dx.doi.org/10.1038/icb.2009.107; PMID: 20065994
   PubMed Web of Science ®Google Scholar
• Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 2004; 22:503 - 29; http://dx.doi.org/10.1146/annurev.immunol.22.091003.090312; PMID: 15032587
   PubMed Web of Science ®Google Scholar
• Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245 - 8; http://dx.doi.org/10.1038/362245a0; PMID: 8384701
   PubMed Web of Science ®Google Scholar
• Pernis AB, Rothman PB. JAK-STAT signaling in asthma. J Clin Invest 2002; 109:1279 - 83; PMID: 12021241
   PubMed Web of Science ®Google Scholar
• Reichle ME, Chen L, Lin SX, Chan LS. The Th2 systemic immune milieu enhances cutaneous inflammation in the K14-IL-4-transgenic atopic dermatitis model. J Invest Dermatol 2011; 131:791 - 4; http://dx.doi.org/10.1038/jid.2010.382; PMID: 21191418
   PubMed Web of Science ®Google Scholar
• Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997; 16:161 - 70; http://dx.doi.org/10.1038/ng0697-161; PMID: 9171827
   PubMed Web of Science ®Google Scholar
• Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res 2011; 50:87 - 96; http://dx.doi.org/10.1007/s12026-011-8205-2; PMID: 21442426
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhou B. Functions of thymic stromal lymphopoietin in immunity and disease. Immunol Res 2012; 52:211 - 23; http://dx.doi.org/10.1007/s12026-012-8264-z; PMID: 22274860
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012; 36:542 - 50; http://dx.doi.org/10.1016/j.immuni.2012.03.014; PMID: 22520847
   PubMed Web of Science ®Google Scholar
• Wohlmann A, Sebastian K, Borowski A, Krause S, Friedrich K. Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function. Biol Chem 2010; 391:181 - 6; http://dx.doi.org/10.1515/bc.2010.029; PMID: 20128689
   PubMed Web of Science ®Google Scholar
• Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol 2003; 3:909 - 20; http://dx.doi.org/10.1016/S1567-5769(02)00235-7; PMID: 12810348
   PubMed Web of Science ®Google Scholar
• Elliott KA, Osna NA, Scofield MA, Khan MM. Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. Int Immunopharmacol 2001; 1:1923 - 37; http://dx.doi.org/10.1016/S1567-5769(01)00117-5; PMID: 11606024
   PubMed Web of Science ®Google Scholar
• Osna N, Elliott K, Chaika O, Patterson E, Lewis RE, Khan MM. Histamine utilizes JAK-STAT pathway in regulating cytokine production. Int Immunopharmacol 2001; 1:759 - 62; http://dx.doi.org/10.1016/S1567-5769(01)00009-1; PMID: 11357887
   PubMed Web of Science ®Google Scholar
• Horr B, Borck H, Thurmond R, Grösch S, Diel F. STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. Int Immunopharmacol 2006; 6:1577 - 85; http://dx.doi.org/10.1016/j.intimp.2006.06.005; PMID: 16919830
   PubMed Web of Science ®Google Scholar
• Stritesky GL, Muthukrishnan R, Sehra S, Goswami R, Pham D, Travers J, et al. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 2011; 34:39 - 49; http://dx.doi.org/10.1016/j.immuni.2010.12.013; PMID: 21215659
   PubMed Web of Science ®Google Scholar
• Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY, et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol 2008; 9:1288 - 96; http://dx.doi.org/10.1038/ni.1656; PMID: 18820682
   PubMed Web of Science ®Google Scholar
• Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10:39 - 49; http://dx.doi.org/10.1016/S1074-7613(00)80005-9; PMID: 10023769
   PubMed Web of Science ®Google Scholar
• Akira S. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 1999; 17:138 - 46; http://dx.doi.org/10.1002/stem.170138; PMID: 10342556
   PubMed Web of Science ®Google Scholar
• Sehra S, Bruns HA, Ahyi AN, Nguyen ET, Schmidt NW, Michels EG, et al. IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6. J Immunol 2008; 180:3551 - 9; PMID: 18292582
   PubMed Web of Science ®Google Scholar
• Weidinger S, Klopp N, Wagenpfeil S, Rümmler L, Schedel M, Kabesch M, et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 2004; 41:658 - 63; http://dx.doi.org/10.1136/jmg.2004.020263; PMID: 15342695
   PubMed Web of Science ®Google Scholar
• Tamura K, Arakawa H, Suzuki M, Kobayashi Y, Mochizuki H, Kato M, et al. Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases. Clin Exp Allergy 2001; 31:1509 - 14; http://dx.doi.org/10.1046/j.1365-2222.2001.01191.x; PMID: 11678849
   PubMed Web of Science ®Google Scholar
• Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270:797 - 800; http://dx.doi.org/10.1126/science.270.5237.797; PMID: 7481768
   PubMed Web of Science ®Google Scholar
• Ortmann RA, Cheng T, Visconti R, Frucht DM, O’Shea JJ. Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res 2000; 2:16 - 32; http://dx.doi.org/10.1186/ar66; PMID: 11094415
   PubMedGoogle Scholar
• Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25:745 - 55; http://dx.doi.org/10.1016/j.immuni.2006.09.009; PMID: 17088085
   PubMed Web of Science ®Google Scholar
• Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 2011; 208:235 - 49; http://dx.doi.org/10.1084/jem.20100799; PMID: 21300911
   PubMed Web of Science ®Google Scholar
• Zhang Q, Su HC. Hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr 2011; 23:653 - 8; http://dx.doi.org/10.1097/MOP.0b013e32834c7f65; PMID: 21970826
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol 2009; 21:105 - 12; http://dx.doi.org/10.1093/intimm/dxn134; PMID: 19088064
   PubMed Web of Science ®Google Scholar
• Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 2008; 129:448 - 54; http://dx.doi.org/10.1016/j.clim.2008.08.002; PMID: 18835223
   PubMed Web of Science ®Google Scholar
• Knosp CA, Carroll HP, Elliott J, Saunders SP, Nel HJ, Amu S, et al. SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses. J Exp Med 2011; 208:1523 - 31; http://dx.doi.org/10.1084/jem.20101167; PMID: 21646394
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Lahesmaa R, Vahedi G, Laurence A, Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat Rev Immunol 2011; 11:239 - 50; http://dx.doi.org/10.1038/nri2958; PMID: 21436836
   PubMed Web of Science ®Google Scholar
• Nakagawa R, Yoshida H, Asakawa M, Tamiya T, Inoue N, Morita R, et al. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17. J Immunol 2011; 187:4611 - 20; http://dx.doi.org/10.4049/jimmunol.1100649; PMID: 21957150
   PubMed Web of Science ®Google Scholar
• Owczarek W, Paplińska M, Targowski T, Jahnz-Rózyk K, Paluchowska E, Kucharczyk A, et al. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis. Cytokine 2010; 50:181 - 5; http://dx.doi.org/10.1016/j.cyto.2010.02.016; PMID: 20236835
   PubMed Web of Science ®Google Scholar
• Kapp A. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity]. Hautarzt 1993; 44:432 - 6; PMID: 8365876
   PubMed Web of Science ®Google Scholar
• Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985; 313:282 - 5; http://dx.doi.org/10.1056/NEJM198508013130502; PMID: 3892296
   PubMed Web of Science ®Google Scholar
• Chen L, Overbergh L, Mathieu C, Chan LS. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model. Clin Exp Allergy 2008; 38:1367 - 80; http://dx.doi.org/10.1111/j.1365-2222.2008.02987.x; PMID: 18489026
   PubMed Web of Science ®Google Scholar
• Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380:630 - 3; http://dx.doi.org/10.1038/380630a0; PMID: 8602264
   PubMed Web of Science ®Google Scholar
• Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002; 168:2020 - 7; PMID: 11823539
   PubMed Web of Science ®Google Scholar
• Cheung PF, Wong CK, Ho AW, Hu S, Chen DP, Lam CW. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol 2010; 22:453 - 67; http://dx.doi.org/10.1093/intimm/dxq027; PMID: 20410259
   PubMed Web of Science ®Google Scholar
• Cornelissen C, Lüscher-Firzlaff J, Baron JM, Lüscher B. Signaling by IL-31 and functional consequences. Eur J Cell Biol 2012; 91:552 - 66; http://dx.doi.org/10.1016/j.ejcb.2011.07.006; PMID: 21982586
   PubMed Web of Science ®Google Scholar
• Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy 2012; 42:712 - 37; http://dx.doi.org/10.1111/j.1365-2222.2011.03854.x; PMID: 22092535
   PubMed Web of Science ®Google Scholar
• Takatsu K, Nakajima H. IL-5 and eosinophilia. Curr Opin Immunol 2008; 20:288 - 94; http://dx.doi.org/10.1016/j.coi.2008.04.001; PMID: 18511250
   PubMed Web of Science ®Google Scholar
• Kotsimbos AT, Hamid Q. IL-5 and IL-5 receptor in asthma. Mem Inst Oswaldo Cruz 1997; 92:Suppl 2 75 - 91; http://dx.doi.org/10.1590/S0074-02761997000800012; PMID: 9698919
   PubMed Web of Science ®Google Scholar
• Ochiai K, Tanabe E, Ishihara C, Kagami M, Sugiyama T, Sueishi M, et al. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma). Clin Exp Immunol 1999; 118:340 - 3; http://dx.doi.org/10.1046/j.1365-2249.1999.01068.x; PMID: 10594549
   PubMed Web of Science ®Google Scholar
• Honda T, Miyachi Y, Kabashima K. Regulatory T cells in cutaneous immune responses. J Dermatol Sci 2011; 63:75 - 82; PMID: 21708454
   PubMed Web of Science ®Google Scholar
• Agrawal R, Wisniewski JA, Woodfolk JA. The role of regulatory T cells in atopic dermatitis. Curr Probl Dermatol 2011; 41:112 - 24; http://dx.doi.org/10.1159/000323305; PMID: 21576952
   PubMedGoogle Scholar
• Hayashida S, Uchi H, Moroi Y, Furue M. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. J Dermatol Sci 2011; 61:180 - 6; http://dx.doi.org/10.1016/j.jdermsci.2010.10.013; PMID: 21255981
   PubMed Web of Science ®Google Scholar
• Fyhrquist N, Lehtimäki S, Lahl K, Savinko T, Lappeteläinen AM, Sparwasser T, et al. Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis. J Invest Dermatol 2012; 132:1672 - 80; http://dx.doi.org/10.1038/jid.2012.40; PMID: 22402436
   PubMed Web of Science ®Google Scholar
• Chapoval S, Dasgupta P, Dorsey NJ, Keegan AD. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukoc Biol 2010; 87:1011 - 8; http://dx.doi.org/10.1189/jlb.1209772; PMID: 20335310
   PubMed Web of Science ®Google Scholar
• Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT, et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007; 109:4368 - 75; http://dx.doi.org/10.1182/blood-2006-11-055756; PMID: 17227828
   PubMed Web of Science ®Google Scholar
• Watcharanurak K, Nishikawa M, Takahashi Y, Kabashima K, Takahashi R, Takakura Y. Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice. Gene Ther 2012; 20:538 - 44; http://dx.doi.org/10.1038/gt.2012.69; PMID: 22914497
   PubMed Web of Science ®Google Scholar
• Brandt C, Pavlovic V, Radbruch A, Worm M, Baumgrass R. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy 2009; 64:1588 - 96; http://dx.doi.org/10.1111/j.1398-9995.2009.02054.x; PMID: 19432936
   PubMed Web of Science ®Google Scholar
• Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282:9358 - 63; http://dx.doi.org/10.1074/jbc.C600321200; PMID: 17277312
   PubMed Web of Science ®Google Scholar
• Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O’Shea JJ. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 2010; 21:425 - 34; http://dx.doi.org/10.1016/j.cytogfr.2010.10.006; PMID: 21084214
   PubMed Web of Science ®Google Scholar
• Cavani A, Pennino D, Eyerich K. Th17 and Th22 in skin allergy. Chem Immunol Allergy 2012; 96:39 - 44; http://dx.doi.org/10.1159/000331870; PMID: 22433369
   PubMedGoogle Scholar
• Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Zaba LC, Cardinale I, Nograles KE, et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008; 181:7420 - 7; PMID: 18981165
   PubMed Web of Science ®Google Scholar
• Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. Mast cells in atopic dermatitis. Curr Opin Immunol 2009; 21:666 - 78; http://dx.doi.org/10.1016/j.coi.2009.09.006; PMID: 19828304
   PubMed Web of Science ®Google Scholar
• Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Vasiadi M, Therianou A, et al. IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One 2012; 7:e33271; http://dx.doi.org/10.1371/journal.pone.0033271; PMID: 22413008
   PubMed Web of Science ®Google Scholar
• Esche C, de Benedetto A, Beck LA. Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep 2004; 4:276 - 84; http://dx.doi.org/10.1007/s11882-004-0071-8; PMID: 15175141
   PubMed Web of Science ®Google Scholar
• Pastore S, Mascia F, Girolomoni G. The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 2006; 16:125 - 31; PMID: 16581561
   PubMed Web of Science ®Google Scholar
• Bao L, Shi VY, Chan LS. IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: Relevant in the pathogenesis of atopic dermatitis. Cytokine 2012.
   Google Scholar
• Hatano Y, Adachi Y, Elias PM, Crumrine D, Sakai T, Kurahashi R, et al. The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis. Exp Dermatol 2013; 22:30 - 5; http://dx.doi.org/10.1111/exd.12047; PMID: 23173934
   PubMed Web of Science ®Google Scholar
• Brandt EB, Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol 2011; 2; http://dx.doi.org/10.4172/2155-9899.1000110; PMID: 21994899
   PubMedGoogle Scholar
• Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128:2248 - 58; http://dx.doi.org/10.1038/jid.2008.74; PMID: 18385759
   PubMed Web of Science ®Google Scholar
• Jiang H, Harris MB, Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 2000; 105:1063 - 70; http://dx.doi.org/10.1067/mai.2000.107604; PMID: 10856136
   PubMed Web of Science ®Google Scholar
• Wery-Zennaro S, Letourneur M, David M, Bertoglio J, Pierre J. Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation. FEBS Lett 1999; 464:91 - 6; http://dx.doi.org/10.1016/S0014-5793(99)01680-4; PMID: 10611490
   PubMed Web of Science ®Google Scholar
• Wu AH, Low WC. Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter. Neuro Oncol 2003; 5:179 - 87; http://dx.doi.org/10.1215/S1152851702000510; PMID: 12816724
   PubMed Web of Science ®Google Scholar
• Hussein YM, Ahmad AS, Ibrahem MM, Elsherbeny HM, Shalaby SM, El-Shal AS, et al. Interleukin 13 receptors as biochemical markers in atopic patients. J Investig Allergol Clin Immunol 2011; 21:101 - 7; PMID: 21462799
   PubMed Web of Science ®Google Scholar
• Yawalkar N, Uguccioni M, Schärer J, Braunwalder J, Karlen S, Dewald B, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999; 113:43 - 8; http://dx.doi.org/10.1046/j.1523-1747.1999.00619.x; PMID: 10417617
   PubMed Web of Science ®Google Scholar
• Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Nakamura K, et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003; 134:309 - 13; http://dx.doi.org/10.1046/j.1365-2249.2003.02273.x; PMID: 14616792
   PubMed Web of Science ®Google Scholar
• Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M, et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 2001; 276:6675 - 88; http://dx.doi.org/10.1074/jbc.M001748200; PMID: 11053426
   PubMed Web of Science ®Google Scholar
• Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 2000; 19:2628 - 37; http://dx.doi.org/10.1038/sj.onc.1203481; PMID: 10851062
   PubMed Web of Science ®Google Scholar
• Yuan ZL, Guan YJ, Chatterjee D, Chin YE. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005; 307:269 - 73; http://dx.doi.org/10.1126/science.1105166; PMID: 15653507
   PubMed Web of Science ®Google Scholar
• Miyata S, Matsuyama T, Kodama T, Nishioka Y, Kuribayashi K, Takeda K, et al. STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy 1999; 29:114 - 23; http://dx.doi.org/10.1046/j.1365-2222.1999.00405.x; PMID: 10051710
   PubMed Web of Science ®Google Scholar
• He R, Kim HY, Yoon J, Oyoshi MK, MacGinnitie A, Goya S, et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol 2009; 124:761 - 70, e1; http://dx.doi.org/10.1016/j.jaci.2009.07.040; PMID: 19815118
   PubMed Web of Science ®Google Scholar
• Bao L, Alexander J, Shi VY, Chan LS. IL-4 up-regulates epidermal IL-19 expression in atopic dermatitis. J Invest Dermatol 2012; 132:Suppl 1 S1 - S18; http://dx.doi.org/10.1038/jid.2012.79
   Google Scholar
• Schittek B. The antimicrobial skin barrier in patients with atopic dermatitis. Curr Probl Dermatol 2011; 41:54 - 67; http://dx.doi.org/10.1159/000323296; PMID: 21576947
   PubMedGoogle Scholar
• Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, Girolomoni G, et al. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 2006; 121:332 - 8; http://dx.doi.org/10.1016/j.clim.2006.08.008; PMID: 17015038
   PubMed Web of Science ®Google Scholar
• Howell MD, Novak N, Bieber T, Pastore S, Girolomoni G, Boguniewicz M, et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005; 125:738 - 45; http://dx.doi.org/10.1111/j.0022-202X.2005.23776.x; PMID: 16185274
   PubMed Web of Science ®Google Scholar
• Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006; 24:341 - 8; http://dx.doi.org/10.1016/j.immuni.2006.02.006; PMID: 16546102
   PubMed Web of Science ®Google Scholar
• Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol 2012; 30:329 - 34; http://dx.doi.org/10.1016/j.clindermatol.2011.08.023; PMID: 22507048
   PubMed Web of Science ®Google Scholar
• Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008; 126:332 - 7; http://dx.doi.org/10.1016/j.clim.2007.11.006; PMID: 18166499
   PubMed Web of Science ®Google Scholar
• Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120:150 - 5; http://dx.doi.org/10.1016/j.jaci.2007.04.031; PMID: 17512043
   PubMed Web of Science ®Google Scholar
• Sawada E, Yoshida N, Sugiura A, Imokawa G. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis. J Dermatol Sci 2012; 68:25 - 35; http://dx.doi.org/10.1016/j.jdermsci.2012.07.004; PMID: 22884781
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis?. Curr Allergy Asthma Rep 2008; 8:306 - 11; http://dx.doi.org/10.1007/s11882-008-0049-z; PMID: 18606082
   PubMed Web of Science ®Google Scholar
• Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5:752 - 60; http://dx.doi.org/10.1038/ni1084; PMID: 15184896
   PubMed Web of Science ®Google Scholar
• Kasraie S, Niebuhr M, Baumert K, Werfel T. Functional effects of interleukin 31 in human primary keratinocytes. Allergy 2011; 66:845 - 52; http://dx.doi.org/10.1111/j.1398-9995.2011.02545.x; PMID: 21261663
   PubMed Web of Science ®Google Scholar
• Lee CH, Hong CH, Yu WT, Chuang HY, Huang SK, Chen GS, et al. Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis. Br J Dermatol 2012; 167:794 - 803; http://dx.doi.org/10.1111/j.1365-2133.2012.11047.x; PMID: 22578170
   PubMed Web of Science ®Google Scholar